Skip to search formSkip to main contentSkip to account menu

YTR-830H

Known as: YTR 830H 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tazobactam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam.
The multiplication of Mycobacterium leprae in foot pads of experimentally-infected mice was suppressed by intramuscular… 
1989
1989
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
1989
1989
In vitro activity of YTR-830H in combination with beta-lactamase unstable beta-lactams.
1988
1988
Degradation of beta-lactamase inhibitor, (2S,3R,5S)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thi a-1- azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide (YTR-830H), in aqueous solutions…
(2S, 3R, 5S)-3-Methyl-7-oxo-3-(1H-1, 2, 3-triazol-1-yl-methyl)-4-thia-l-azabicyclo [3.2.0]-heptane-2-carboxylic acid 4, 4-dioxide… 
1988
1988
High-performance liquid chromatographic determination of a new beta-lactamase inhibitor and its metabolite in combination therapy with piperacillin in biological materials.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)